Charles Conway

Insider Reports History

Entity
Individual
Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Conway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Scientific Officer Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Charles Conway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 16 -$3.32M 4 Oct 3, 2022 Chief Scientific Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 5 -$223K 4 Jan 7, 2022 Chief Scientific Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 23, 2021 6 $394K 4 Nov 26, 2021 Chief Scientific Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 7, 2017 1 $0 4/A Nov 26, 2021 Chief Scientific Officer